Список литературы

Поставить закладку

Gran O.V., Braekhan S.K., Hansen J.B. Protrombotic genotypes and risk of venous thromboembolism in cancer// Thrombosis Research, 2018. V.164, P.12-18.
Khorana AA, Cohen A.T., Carrier M. et al. Prevention of venous thromboembolism in ambulatory patients with cancer//ESMO Open. 2020. V.5;000948, doi: 10.1136/esmoopen-2020- 000948.
Андрияшкин В.В., Сомонова О.В., Пантелеев М.А. и др. Диагностика, лечение и профилактика тромбоэмболических осложнений у онкологических и онкогематологических больных. Учебное пособие, М.: ФГБОУ ДПО РМАНПО Минздрава России, 2018, 76 стр. ISBN 978-5-7249-2842-7.
Kakkos S.K., Gohel M., Baekgaard N. et al. European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis// Eur J Vasc Endovasc Surg, 2021, V. 61, P. 9 -82.
Wun T, White RH. Epidemiology of cancer-related venous thromboembolism// Best Pract Res Clin Haemotol., 2009. V.22 N.1. P.9–23.
Shaib W, Deng Y, Zilterman D et al. Assessing risk and mortality of venous thromboembolism in pancreatic cancer patients// Anticancer Res., 2010. V.30 N.10, P.4261– 4264.
Ogren M, Bergqvist D, Wahlander K et al. Trousseaus syndrome –what is the evidence? A population – based autopsy study//Thromb Haemost., 2006. V.95, P.541–545.
Cтойко Ю.М., Кириенко А.И., Затевахин И.И. и др. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений (ВТЭО)//Флебология, 2018. V.12 N.3, P.146-240.
Key N.S., Khorana A.A., Kuderer N.M. et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update// J.Clin. Oncol., 2020. V.38, No 5. P.496-520. Doi:10.1200/JCO.19.01461.PMID:31381464.
Steffel J., Collins R., Antz M. et al. 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation// Europace, 2021. V.00, P.1–65 doi:10.1093/europacej/euab065.
Konstantinides S.V., Meyer G., Becattini C. et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) // European Heart Journal, 2020. V. 41, P.543-603. doi:10.1093/eurheartj/ehz 405.
Streiff M.B., Angelini D., Ashrani A. et al. NCCN Guidelines Cancer-Associated Venous Thromboembolic Disease. Version 1.2021- March 17, 2021.
Young AM, Marshall A, Thirlwall J et al. Comparison of an oral factorXa inhibitor with low molecular weight heparin in patients with cancerwith venous thromboembolism: results of a randomized trial (SELECT-D// J Clin Oncol., 2018. V.36 N.20, P.2017–2023.
Khorana AA, Noble S, Lee AY et al. Role of direct oral anticoagulants inthe treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH// J Thromb Haemost., 2018. V.16, P.1891–1894.
Kearon C., Akl E.A., Ornelas J., et al Antithrombotic Therapy for VTE Disease. CHEST Guideline and Expert Panel Report// Chest , 2016. V.149, P. 315-352.
Pabinger I., van Es N., Heinze G, et al. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts// Lancet Haematol., 2018. V.5., P.e289-298.
Khorana AA, DeSancho M.T., Liebman H.. et al. Prediction and prevention of cancer- associated thromboembolism. The oncologist. 2021. V.26 (1): e2-e7. doi: 10.1002onco.13569.
Ortel T.L.,Neumann I., Ageno W. et al. American society of hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary emboliasm. Blood Adv., 2020. Vol. 4, N 19. P. 4693-4738. DOI:10.1182/bloodadvances.2020001830.
Черкасов В.А., Долгушин Б.И., Андреев Ю.Г., Сомонова О.В. Кавафильтр «Корона»: применение у онкологических больных, особенности конструкции и техники выполнения. Онкологический журнал. 2018; 1 (1): 53-59.
Черкасов В.А., Долгушин Б.И., Андреев Ю.Г., Сомонова О.В., Францев Д.Ю. Кавафильтр «Корона». Аспекты клинического применения у онкологических больных. Особенности конструкции и техники выполнения. Медицинский алфавит. Диагностика и онкотерапия. 2017; 2 (25): 47-52.